Hospital
Unity Health - Newport
Unity Health - Newport was paid $1.00M by Medicaid between Nov 2021 and Dec 2024, across 92 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 14% of everything it billed.
33Billing provider infoUNITY HEALTH - NEWPORT
NEWPORT, AR 72112
NEWPORT, AR 72112
33aNPI1508450339assigned 02/23/2021
33bProvider typeCritical Access Hospital
28Total paid$1.00M
24GClaims58,201
24DCodes billed92
24AFirst – last monthNov 2021 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Arkansas
Rank by total paid#15 of 34
Median peer was paid$773K
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 1,657 | $13K | |
| 2022 | 19,043 | $273K | |
| 2023 | 24,700 | $432K | |
| 2024incomplete | 12,801 | $283K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 14% | 4,309 | 3,335 | $137K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 10% | 3,270 | 2,795 | $100K |
| 70450 | Computed tomography, head or brain; without contrast material | 8.8% | 882 | 738 | $88K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.0% | 372 | 313 | $60K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.6% | 1,349 | 1,081 | $46K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.2% | 5,395 | 4,159 | $42K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.1% | 809 | 687 | $41K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.0% | 510 | 422 | $40K |
| 84484 | 2.8% | 1,860 | 1,382 | $28K | |
| 83880 | 2.6% | 951 | 777 | $26K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 2.6% | 89 | 82 | $26K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.5% | 2,552 | 1,976 | $25K |
80 more codes
| 99283 | Emergency room visit (moderate) | 2.5% | 892 | $25K |
| 71045 | Radiologic examination, chest; single view | 2.4% | 2,323 | $24K |
| 99285 | Emergency room visit (most serious) | 2.0% | 695 | $20K |
| 99284 | Emergency room visit (serious) | 1.9% | 1,010 | $19K |
| 99499 | 1.8% | 1,137 | $18K | |
| 87400 | 1.8% | 3,703 | $18K | |
| 36415 | Collection of venous blood by venipuncture | 1.7% | 1,763 | $17K |
| 83690 | 1.6% | 1,384 | $16K | |
| 82550 | 1.2% | 1,055 | $12K | |
| 81001 | 1.1% | 3,483 | $11K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 210 | $10K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,176 | $9K |
| 84145 | <1% | 244 | $9K | |
| 84703 | <1% | 1,259 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 357 | $8K |
| 83605 | <1% | 354 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 381 | $8K |
| 82553 | <1% | 485 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 670 | $6K |
| 86901 | <1% | 249 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 327 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 599 | $5K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 125 | $4K |
| 87430 | <1% | 704 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 258 | $4K |
| 80076 | <1% | 85 | $4K | |
| 85610 | <1% | 826 | $3K | |
| 87081 | <1% | 473 | $3K | |
| 82805 | <1% | 82 | $3K | |
| 87420 | <1% | 433 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 906 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,244 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 568 | $2K |
| 85730 | <1% | 475 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 176 | $2K |
| 83735 | <1% | 325 | $2K | |
| 85027 | <1% | 455 | $2K | |
| 87088 | <1% | 270 | $2K | |
| 80320 | <1% | 189 | $2K | |
| 86900 | <1% | 249 | $2K | |
| 81025 | <1% | 230 | $2K | |
| 80329 | <1% | 250 | $2K | |
| 82150 | <1% | 115 | $1K | |
| 87040 | <1% | 117 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 26 | $1K |
| 82948 | <1% | 258 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 333 | $1K |
| 80061 | Lipid panel | <1% | 149 | $1K |
| 86885 | <1% | 169 | $822.41 | |
| 87186 | <1% | 146 | $791.84 | |
| 73610 | <1% | 13 | $734.97 | |
| 80050 | General health panel | <1% | 14 | $632.71 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 63 | $598.00 |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $560.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 169 | $406.80 |
| 84702 | <1% | 38 | $402.52 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 24 | $399.78 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 85 | $340.63 |
| 73630 | <1% | 14 | $286.72 | |
| 73130 | <1% | 19 | $225.00 | |
| 85007 | <1% | 17 | $216.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 364 | $181.07 |
| 86850 | <1% | 18 | $137.00 | |
| 82947 | <1% | 24 | $122.64 | |
| 85379 | <1% | 13 | $101.71 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 17 | $79.42 |
| 99001 | <1% | 121 | $78.00 | |
| J2704 | Injection, propofol, 10 mg | <1% | 161 | $77.29 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 127 | $75.07 |
| 86592 | <1% | 12 | $71.20 | |
| 86593 | <1% | 12 | $62.90 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 16 | $38.96 |
| 85014 | <1% | 12 | $30.42 | |
| 85018 | <1% | 12 | $30.42 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 31 | $24.24 |
| J3490 | Unclassified drugs | <1% | 89 | $24.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 31 | $13.78 |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | <1% | 17 | $11.29 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 188 | $2.32 |
| A9270 | Non-covered item or service | 0% | 728 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSTON, LADONNA (VP/ADMINISTRATOR)